ANI Pharmaceuticals (ANIP) Earnings Date, Estimates & Call Transcripts → Elon Musk Secret Crypto Plot Exposed (From Crypto 101 Media) (Ad) Free anip Stock Alerts $68.05 +2.17 (+3.29%) (As of 05/10/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Earnings SummaryLatest Earnings DateFeb. 29ConfirmedActual EPS (Feb. 29) $0.78 Beat By $0.20 Consensus EPS (Feb. 29) $0.58 Get ANI Pharmaceuticals Earnings AlertsEnter your email address below to receive the latest news and earnings results for ANIP and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueANIP Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.ANIP Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Crypto 101 MediaElon Musk Secret Crypto Plot ExposedReports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.Click here now to get your copy. ANI Pharmaceuticals Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20241$0.72$0.72$0.72 Q2 20241$0.84$0.84$0.84 Q3 20241$1.03$1.03$1.03 Q4 20241$1.09$1.09$1.09 FY 20244$3.68$3.68 $3.68ANIP Earnings Date and InformationANI Pharmaceuticals last announced its quarterly earnings results on May 10th, 2024. The specialty pharmaceutical company reported $1.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.98 by $0.24. The company earned $137.40 million during the quarter, compared to analyst estimates of $126.03 million. Its revenue for the quarter was up 28.7% compared to the same quarter last year. ANI Pharmaceuticals has generated $0.84 earnings per share over the last year ($0.84 diluted earnings per share) and currently has a price-to-earnings ratio of 81.0. Earnings for ANI Pharmaceuticals are expected to grow by 16.62% in the coming year, from $3.55 to $4.14 per share. ANI Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Friday, May 10th, 2024. Read More ANI Pharmaceuticals Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript2/29/2024Q4 2023$0.58$0.78+$0.20$1.52$123.02 million$131.65 million11/8/2023Q3 2023$0.84$1.27+$0.43$1.65$111.92 million$131.83 million 8/9/2023Q2 2023$0.64$1.28+$0.64$1.83$99.87 million$116.50 million 5/8/2023Q1 2023$0.16$0.97+$0.81$1.88$82.99 million$106.79 million3/9/2023Q4 2022$0.49$0.59+$0.10$1.46$86.76 million$94.23 million11/9/2022Q3 2022$0.40$0.46+$0.06$1.47$78.71 million$83.82 million Get the Latest News and Ratings for ANIP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ANI Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 8/8/2022Q2 2022($0.04)($0.05)($0.01)$0.84$71.00 million$73.86 million 5/10/2022Q1 2022($0.05)($0.27)($0.22)$0.73$65.50 million$64.48 million 3/15/2022Q4 2021$0.69$0.38($0.31)$2.48$58.25 million$60.93 million 10/31/2021Q3 2021$0.70$1.01+$0.31$2.03$50.30 million$52.06 million 8/5/2021Q2 2021$0.51$0.67+$0.16$2.15$47.80 million$48.63 million ANI Pharmaceuticals Earnings - Frequently Asked Questions When is ANI Pharmaceuticals's earnings date? ANI Pharmaceuticals has confirmed that its next quarterly earnings data will be published on Friday, May 10th, 2024. Learn more on ANIP's earnings history. Did ANI Pharmaceuticals beat their earnings estimates last quarter? In the previous quarter, ANI Pharmaceuticals (NASDAQ:ANIP) reported $1.21 earnings per share (EPS) to beat the analysts' consensus estimate of $0.98 by $0.24. Learn more on analysts' earnings estimate vs. ANIP's actual earnings. How can I listen to ANI Pharmaceuticals's earnings conference call? The conference call for ANI Pharmaceuticals's latest earnings report can be listened to online. Listen to Conference Call How can I view ANI Pharmaceuticals's earnings report? ANI Pharmaceuticals's earnings report can be found in their filing with the SEC. View SEC filing How much revenue does ANI Pharmaceuticals generate each year? ANI Pharmaceuticals (NASDAQ:ANIP) has a recorded annual revenue of $486.82 million. How much profit does ANI Pharmaceuticals generate each year? ANI Pharmaceuticals (NASDAQ:ANIP) has a recorded net income of $18.78 million. ANIP has generated $0.84 earnings per share over the last four quarters. What is ANI Pharmaceuticals's price-to-earnings ratio? ANI Pharmaceuticals (NASDAQ:ANIP) has a trailing price-to-earnings ratio of 81.01 and a forward price-to-earnings ratio of 19.17. What is ANI Pharmaceuticals's EPS forecast for next year? ANI Pharmaceuticals's earnings are expected to grow from $3.55 per share to $4.14 per share in the next year, which is a 16.62% increase. More Earnings Resources from MarketBeat Related Companies: Arcus Biosciences Earnings Date Akero Therapeutics Earnings Date Morphic Earnings Date Gyre Therapeutics Earnings Date Kiniksa Pharmaceuticals Earnings Date Protagonist Therapeutics Earnings Date Dynavax Technologies Earnings Date Ardelyx Earnings Date Xencor Earnings Date Day One Biopharmaceuticals Earnings Date Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:ANIP) was last updated on 5/11/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchGold Set to EXPLODE!Gold Safe ExchangeHow Biden has already won 2024Porter & CompanyForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ANI Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
